Abstract
We provide immense insulin absorption from the gastrointestinal tract, combining apical sodium-dependent bile acid transporter-mediated intestinal uptake and the lymphatic transport pathway. This strategy has proven to employ chondroitin sulfate-g-taurocholic acid coated, insulin-loaded partially uncapped liposome (IPUL-CST) for type 1 diabetes mellitus (T1DM) treatment. The loading efficiency of insulin in IPUL-CST increased significantly from 33% to 75% via the partially uncapped liposome preparation method. Moreover, the IPUL-CST revealed an improved insulin protection efficacy in GIT simulated pH and digestive enzyme conditions. The high dose of IPUL-CST in the small intestine was detected 4 h post-oral administration using ex vivo optical imaging and fluorescence intensity. The IPUL-CST exhibited significantly enhanced intestinal absorption (oral bioavailability, 34%; T max , 9 h) and reduced blood glucose levels for 16 h in T1DM. The results demonstrated that the new investigated IPUL-CST is a promising carrier for oral insulin delivery.
Original language | English |
---|---|
Pages (from-to) | 4756-4763 |
Number of pages | 8 |
Journal | Molecular Pharmaceutics |
Volume | 15 |
Issue number | 10 |
DOIs | |
State | Published - 1 Oct 2018 |
Bibliographical note
Funding Information:This work was partially supported by the National Institutes of Health (NIH DK114015-01).
Publisher Copyright:
© 2018 American Chemical Society.
Keywords
- chondroitin sulfate coated liposome
- long acting insulin
- massive intestinal absorption
- oral insulin delivery
- taurocholic acid